Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
RCT	373 adults aged 18 to 75 years with recent-onset sore throat (≤4 days)	Serious adverse events at day 3 0/186 (0%) with flurbiprofen 0/187 (0%) with placebo	Significance assessment not reported
RCT	373 adults aged 18 to 75 years with recent-onset sore throat (≤4 days)	Gastrointestinal adverse events at day 3 9/186 (4.8%) with flurbiprofen 8/187 (4.3%) with placebo	Significance assessment not reported